Nanomaterials for targeted therapy of kidney diseases: Strategies and advances

Area of Science:

• Nephrology
• Nanotechnology
• Drug Delivery

Background:

• Kidney diseases present a significant global health challenge.
• Current drug therapies for kidney diseases are limited by poor targeting, short half-life, and systemic side effects due to biological barriers.
• Development of kidney-targeted therapeutic agents is crucial for clinical progress.

Purpose of the Study:

• To review the application of nanomedicine in targeted therapy for kidney diseases.
• To discuss the advantages and limitations of current nanomedicine approaches in nephrology.
• To summarize renal targeting strategies and future prospects in kidney-targeted nanomedicine.

Main Methods:

• Review of existing literature on nanomedicine in nephrology.
• Analysis of nanomaterial design for kidney targeting.
• Summary of passive and active renal targeting strategies.

Main Results:

• Nanomaterials can be designed with optimal biological characteristics for improved circulation, retention, targeting, and excretion.
• Rational design based on kidney anatomy and pathophysiology enables specific kidney-targeted nanodrug delivery systems.
• Current nanomedicine strategies show potential for revolutionizing kidney disease diagnosis and treatment.

Conclusions:

• Nanomedicine holds significant promise for advancing the targeted therapy of kidney diseases.
• Further research into renal active/passive targeting strategies is needed to overcome existing challenges.
• Optimizing nanomaterial design is key to developing effective kidney-targeted nanotherapeutics.